advertisement
Molecular therapy. Methods & clinical development 9
Showing records 1 to 9 | Display all abstracts in Molecular therapy. Methods & clinical development92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Cassidy PS
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92773 Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas
Oswald J
Molecular therapy. Methods & clinical development 2021; 21: 180-198
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Kelly RA
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92773 Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas
Kegeles E
Molecular therapy. Methods & clinical development 2021; 21: 180-198
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Reina-Torres E
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92773 Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas
Minelli T; Volchkov P
Molecular therapy. Methods & clinical development 2021; 21: 180-198
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Sherwood JM
Molecular therapy. Methods & clinical development 2021; 20: 86-94
92773 Transplantation of miPSC/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas
Baranov P
Molecular therapy. Methods & clinical development 2021; 21: 180-198
92815 siRNA targeting Schlemm's canal endothelial tight junctions enhances outflow facility and reduces IOP in a steroid-induced OHT rodent model
Humphries MM; Kiang AS; Farrar GJ; O'Brien C; Campbell M; Stamer WD; Overby DR; Humphries P; O'Callaghan J
Molecular therapy. Methods & clinical development 2021; 20: 86-94
